Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mrfox
    Senior Member
    • Aug 2010
    • 103

    #1

    edgeR: without replicates

    Hi all,
    I have two RNA-Seq samples (normal and treatment) but neither has replicates. In such a case one option is to apply edgeR with Poisson model on our data. But I know that the latest edgeR can do a better job and somehow estimate the biological variation. Unfortunately, I do not know exactly how to implement this. Could anybody help me for this?

    Similar questions have been discussed here:
    Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc
  • Gordon Smyth
    Member
    • Apr 2011
    • 91

    #2
    Estimating biological variation without replicates is tough. edgeR offers the following solution however that will work well when the proportion of transcripts that are differentially expressed is no more than 30%. The solution is part of the new code to fit generalized linear models and to handle multi-factor experiments.

    Suppose that y is your DGEList object. Setup a null design matrix with only an intercept term, then estimate the dispersion robustly from your two samples:

    design0 <- matrix(1,2,1)
    y <- estimateGLMCommonDisp(y,design0,method="deviance",robust=TRUE)

    Then you can use the resulting dispersion estimate y$common.dispersion for your subsequent differential expression analysis.

    We answer questions more regularly on the Bionconductor mailing list than on SEQanswers, so you could post questions there for more details.

    Best wishes
    Gordon

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...